Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Mod Rheumatol ; 28(4): 716-720, 2018 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-26872871

RESUMEN

A 64-year-old woman with leg edema was diagnosed with protein-losing gastroenteropathy and Sjögren's syndrome. Central venous nutrition led to infection of her catheter, ascites, and deep vein thrombosis. Following successful treatment of these conditions with antibiotics and anticoagulants, she was treated unsuccessfully with prednisolone and steroid pulse therapy. Mizoribine add-on markedly reduced edema and normalized serum albumin. This is the first report of a steroid-resistant protein-losing gastroenteropathy patient with Sjögren's syndrome successfully treated with mizoribine.


Asunto(s)
Glucocorticoides/uso terapéutico , Inmunosupresores/uso terapéutico , Prednisolona/uso terapéutico , Enteropatías Perdedoras de Proteínas/tratamiento farmacológico , Ribonucleósidos/uso terapéutico , Síndrome de Sjögren/tratamiento farmacológico , Femenino , Glucocorticoides/administración & dosificación , Humanos , Inmunosupresores/administración & dosificación , Persona de Mediana Edad , Prednisolona/administración & dosificación , Enteropatías Perdedoras de Proteínas/complicaciones , Ribonucleósidos/administración & dosificación , Síndrome de Sjögren/complicaciones
2.
Rheumatol Int ; 30(8): 1103-6, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19585118

RESUMEN

Rheumatoid pericarditis occurs in patients with rheumatoid arthritis (RA). However, cardiac tamponade due to rheumatoid pericarditis is rare; we describe a case of a 72-year-old man with a 6-year history of rheumatoid arthritis who developed rheumatoid pericarditis with recurrent cardiac tamponade. The patient experienced relapse of the cardiac tamponade despite treatment with pericardiocentesis. Therefore, the patient underwent surgical pericardial drainage. The patient was also subsequently treated with increasing doses of corticosteroid, methotrexate and leukocytapheresis. These treatments resulted in a successful outcome without any complication. This case suggests that in addition to immunosuppressive therapy, pericardial drainage should be considered in the treatment of life-threatening refractory cardiac tamponade caused by rheumatoid arthritis.


Asunto(s)
Artritis Reumatoide/complicaciones , Procedimientos Quirúrgicos Cardíacos/métodos , Taponamiento Cardíaco/etiología , Taponamiento Cardíaco/cirugía , Pericarditis/etiología , Pericarditis/cirugía , Succión/métodos , Anciano , Humanos , Masculino , Resultado del Tratamiento
3.
Medicine (Baltimore) ; 94(27): e875, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-26166127

RESUMEN

Few data are available regarding vertebral fracture risk in patients treated with corticosteroids including patients with interstitial lung disease (ILD). The aim of the present study was to identify risk factors for symptomatic vertebral fracture analyzed in patients with newly diagnosed autoimmune diseases.This was an observational cohort study conducted in the National Hospital Organization-EBM study group from 2006 to 2008. The study subjects were autoimmune disease patients who were newly treated with glucocorticoids (GCs). The primary endpoint was the first occurrence of vertebral fracture diagnosed by x-rays. Cox proportional-hazards regression was used to determine independent risk factors for vertebral fracture with covariates including sex, age, comorbidity, laboratory data, use of immunosuppressants, and dose of GCs. Survival was analyzed according to the Kaplan-Meier method and assessed by the log-rank test.Among 604 patients of mean age 59.5 years and mean GC dose 50.4 mg/d (first 1 months), 19 patient (3.1%) had at least 1 symptomatic vertebral fracture during 1.9 years of follow-up period. Cox regression model demonstrated that the relative risk for symptomatic vertebral fracture was independently higher in patient with ILD (hazard ratio [HR] = 2.86, 95% confidence interval [CI] = 1.10-7.42, P = 0.031) and in every 10-year increment of the age of disease onset (HR = 1.57, 95% CI = 1.09-2.26, P = 0.015). Kaplan-Meier analyses demonstrated that the incidence of vertebral fractures in patients with ILD was significantly higher in comparison with those without ILD.Our results indicate a higher risk of vertebral facture in patients with ILD and elderly patients during the initial GC treatment against autoimmune diseases. There is a need for further, even longer-term, prospective studies subjected patients with autoimmune disease, including ILD, under GC treatment.


Asunto(s)
Enfermedades Autoinmunes/complicaciones , Enfermedades Autoinmunes/tratamiento farmacológico , Glucocorticoides/efectos adversos , Enfermedades Pulmonares Intersticiales/complicaciones , Fracturas de la Columna Vertebral/inducido químicamente , Adulto , Factores de Edad , Anciano , Comorbilidad , Relación Dosis-Respuesta a Droga , Femenino , Glucocorticoides/uso terapéutico , Humanos , Inmunosupresores/uso terapéutico , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Modelos de Riesgos Proporcionales , Factores de Riesgo , Factores Sexuales
4.
Intern Med ; 47(7): 663-6, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18379157

RESUMEN

A 30-year-old Japanese man developed dactylitis with sausage-like fingers in addition to balanitis and stomatitis. One year prior to these symptoms, acute chlamydial urethritis had been successfully treated by levofloxacin. On admission, Chlamydia trachomatis DNA was not detected in the urine sediment by PCR method, however, he was diagnosed to have reactive arthritis based on the clinical findings of asymmetric dactylitis, circinate balanitis, stomatitis and positivity for HLA B27 antigen. He was treated with methotrexate and his arthritis improved. The past chlamydial infection may have been involved in the pathogenesis of reactive arthritis in this patient.


Asunto(s)
Artritis Reactiva/diagnóstico , Infecciones por Chlamydia/diagnóstico , Uretritis/diagnóstico , Enfermedad Aguda , Adulto , Antibacterianos/uso terapéutico , Artritis Reactiva/tratamiento farmacológico , Artritis Reactiva/etiología , Infecciones por Chlamydia/complicaciones , Infecciones por Chlamydia/tratamiento farmacológico , Humanos , Masculino , Factores de Tiempo , Uretritis/complicaciones , Uretritis/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA